{"entities":{"Q9885":{"pageid":14046,"ns":120,"title":"Item:Q9885","lastrevid":205038,"modified":"2020-05-20T22:05:37Z","type":"item","id":"Q9885","labels":{"en":{"language":"en","value":"Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9885$325BF9CF-9A2D-4F01-8BA1-DAFC895E1AC8","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9885$44E05116-98CF-4202-B799-ECF45819251F","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Pal SK","type":"string"},"datatype":"string"},"type":"statement","id":"Q9885$4C1D3BFD-FDF5-443F-B35B-FC1C96B9AE2F","rank":"normal"}],"P150":[{"mainsnak":{"snaktype":"value","property":"P150","datavalue":{"value":"Swami U","type":"string"},"datatype":"string"},"type":"statement","id":"Q9885$4787C787-7612-408F-A9AE-4D636D642BFE","rank":"normal"}],"P151":[{"mainsnak":{"snaktype":"value","property":"P151","datavalue":{"value":"Agarwal N","type":"string"},"datatype":"string"},"type":"statement","id":"Q9885$BB4CD921-7577-4988-B80E-F1DA07849474","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2019-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9885$8713AE69-15F2-46EA-8C21-71C9D99F7B44","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Eur. Urol.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9885$F43B7CC2-21E8-44F6-BA7D-BEF3BB19AE85","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Characterizing the Wnt pathway in advanced prostate cancer: when why and how.","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9885$D79FC666-E86C-4FC5-8F0E-35B82159393E","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Pal_SK,_et_al._Eur._Urol._(2019)_cited_as_Ref_622_in_DOI:_10.1038/s41392-020-0110-5"}}}}}